Stay updated on Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial

Sign up to get notified when there's something new on the Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The record history shows the addition of revision v3.4.2 and removal of v3.4.1. This is a metadata update to the page with no changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:25:52.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry v3.4.1 and removes v3.4.0, reflecting a system site update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T00:00:22.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Glossary toggle and color-coded change highlights (green for additions, red for deletions) were added, along with a new Revision: v3.4.0 label; the No FEAR Act data text and the Revision: v3.3.4 entry were removed.
    Difference
    1%
    Check dated 2026-01-28T20:20:44.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    New revision v3.3.4 added to the Record History; the previous revision v3.3.3 is shown in the history.
    Difference
    0.1%
    Check dated 2026-01-14T04:07:06.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-12-23T22:08:46.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The Record History page now includes a new revision entry (v3.3.2) and removes an older revision (v3.2.0), reflecting internal version-tracking rather than substantive changes; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:12:35.000Z thumbnail image

Stay in the know with updates to Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial page.